// App-Quantinova.ai

1838 : Differential CXCL13 and CXCR5 expression mediated by down-regulation of select miRNAs in prostate cancer

Researchers

Presenter

  • Denise E. Hinton

Principal Investigators

  • James Lillard

Medical Centers

  • Morehouse School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • p53

  • C-X-C Motif Chemokine Ligand 13

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved